Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX000357-08 |
| Title: | Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases |
| Principal Investigator: | Rajiv R. Mohan |
| Location: | Columbia, MO |
| Congressional District Code: | 4 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | January 2018 - December 2022 |
| FY 2023 Funding Amount: | $0 |
| Total Award Amount (all years): |
$753,695 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Corneal scarring from ocular trauma is a major cause of blindness in veterans, active military personnel and civilians affecting 1.5 million Americans each year. Presently, over 167,000 Veterans are legally blind, 1.5 million suffer significantly compromised vision, and >7000 veterans are becoming blind each year. The annual cost for treating blindness in America is $139 billion. Current therapies offer short-term relief, cause multiple side effects and often fails to treat preexisting corneal s... |